Antibiotic Treatment for Escherichia coli Infections

First-Line Options

• The American College of Physicians recommends ciprofloxacin as the first-line antibiotic choice for E. coli infections when the organism is susceptible, particularly for systemic infections such as bacteremia 1
• For systemic infections, piperacillin/tazobactam or third-generation cephalosporins may be used for more severe cases 2

Special Considerations

• For multidrug-resistant E. coli, consider carbapenems or newer agents like ceftazidime/avibactam 3
• Extended-spectrum penicillins or extended-spectrum cephalosporins may be needed for multidrug-resistant E. coli 4

Infection Site-Specific Treatment

• For biliary infections, first-line treatment for mild episodes is oral aminopenicillin/beta-lactamase inhibitor, and for severe cases, IV piperacillin/tazobactam or third-generation cephalosporins may be used 2
• For intra-abdominal infections, piperacillin/tazobactam or third-generation cephalosporins with anaerobic coverage may be used 2

Duration of Therapy

• The Infectious Diseases Society of America recommends the following durations of therapy: uncomplicated UTI, 3-7 days; complicated UTI, 5-7 days; bacteremia, 7-14 days; intra-abdominal infections, 5-7 days 3

Combination Therapy

• In cases of severe sepsis, combination therapy may be considered initially until susceptibilities are known 2